Skip to main content
TipRanks
Go Ultimate75% OFF

Elevance Health (A58) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

A58 Analyst Ratings

Moderate Buy
14Ratings
10Buy4Hold0Sell
Based on 14 analysts giving stock ratings to Elevance Health in the past 3 months

A58 Stock 12 Month Forecast

CHF406.42â–²(9.89% Upside)
Based on 14 Wall Street analysts offering 12 month price targets for Elevance Health in the last 3 months. The average price target is CHF 406.42 with a high forecast of CHF 440.99 and a low forecast of CHF 342.34. The average price target represents a 9.89% change from the last price of CHF 369.86.
Highest Price TargetCHF440.99Average Price TargetCHF406.42Lowest Price TargetCHF342.34

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for CH:A58
Price TargetArticle
Argus ResearchCHF320.41→CHF430.03buy16.27%UpsideUpgraded11/18/26
BernsteinCHF438.46buy18.55%UpsideReiterated11/18/26
Mizuho SecuritiesCHF413.17buy11.71%UpsideReiterated11/15/26
Wells FargoCHF398.83→CHF414.85buy12.16%UpsideAssigned10/27/26
TD CowenCHF392.09→CHF417.38buy12.85%UpsideReiterated10/23/26
Bank of America SecuritiesCHF421.60buy13.99%UpsideAssigned10/22/26
BarclaysCHF395.46→CHF397.99buy7.61%UpsideReiterated10/22/26
Robert W. BairdCHF331.38→CHF342.34hold-7.44%DownsideReiterated10/22/26
Morgan StanleyCHF340.65→CHF378.59hold2.36%UpsideReiterated10/22/26
UBSCHF387.87→CHF440.99buy19.23%UpsideAssigned10/22/26
Truist FinancialCHF400.52→CHF421.60buy13.99%UpsideReiterated10/22/26
Goldman SachsCHF333.06→CHF380.28hold2.82%UpsideReiterated10/22/26
GuggenheimCHF387.87→CHF408.95buy10.57%UpsideReiterated10/21/26
RBC CapitalCHF357.51→CHF383.65hold3.73%UpsideReiterated10/21/26
Leerink PartnersCHF306.92→CHF333.06hold-9.95%DownsideReiterated07/17/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PVLAPalvella Therapeutics
IRLAIRulya Therapeutics
RZLTRezolute
PTGXProtagonist Therapeutics
CTMXCytomX Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Elevance Health

3 Months
George Hill
George HillDeutsche Bank
Success Rate12/18 ratings generated profit
67%
Average Return
+3.65%

Copying George Hill's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +3.65% per trade.

1 Year
George Hill
George HillDeutsche Bank
Success Rate14/18 ratings generated profit
78%
Average Return
+15.51%

Copying George Hill's trades and holding each position for 1 Year would result in 77.78% of your transactions generating a profit, with an average return of +15.51% per trade.

2 Years
Success Rate26/30 ratings generated profit
87%
Average Return
+33.95%

Copying A.J. Rice's trades and holding each position for 2 Years would result in 86.67% of your transactions generating a profit, with an average return of +33.95% per trade.

A58 Analyst Recommendation Trends

010203040Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for A58
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy00000
Buy2721202022
Hold99865
Sell00000
Strong Sell00000
total3630282627

In the current month, A58 has received 22 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. A58 average Analyst price target in the past 3 months is 406.42.

A58 Financial Forecast

CHF0CHF2.75CHF5.5CHF8.25CHF11Q1 2026Q3 2026Q4 2026
HighCHF2.72
ConsensusCHF1.76
LowCHF1.38

A58 Earnings Forecast

Next quarter’s earnings estimate for A58 is CHF 1.76 with a range of CHF 1.38 to CHF 2.72. The previous quarter’s EPS was CHF 5.89. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

CHF39.6BCHF40.7BCHF41.7BCHF42.8BCHF43.8BQ1 2026Q3 2026Q4 2026
HighCHF43.8B
ConsensusCHF41.6B
LowCHF39.6B

A58 Sales Forecast

Next quarter’s sales forecast for A58 is CHF 41.63B with a range of CHF 39.65B to CHF 43.85B. The previous quarter’s sales results were CHF 43.36B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

A58 Stock Forecast FAQ

What is CH:A58’s average 12-month price target, according to analysts?
Based on analyst ratings, Elevance Health’s 12-month average price target is CHF406.42.
What is CH:A58’s upside potential, based on the analysts’ average price target?
Elevance Health has 9.89% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Elevance Health a Buy, Sell or Hold?
Elevance Health has a consensus rating of Moderate Buy, which is based on 10 buy ratings, 4 hold ratings and 0 sell ratings.
What is Elevance Health’s share price target?
The average share price target for Elevance Health is CHF406.42. This is based on 14 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF440.99, and the lowest forecast is CHF342.34. The average share price target represents a 9.89% increase from the current price of CHF369.859.
What do analysts say about Elevance Health?
Elevance Health’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 14 Wall Street analysts.
How can I buy shares of Elevance Health?
To buy shares of CH:A58, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.